Rapamycin extends life and health in C57BL/6 mice

Yiqiang Zhang, Alex Bokov, Jonathan A Gelfond, Vanessa Soto, Yuji Ikeno, Gene Hubbard, Vivian Diaz, Lauren Sloane, Keith Maslin, Stephen Treaster, Samantha Réndon, Holly Van Remmen, Walter Ward, Martin A Javors, Arlan Richardson, Steven N. Austad, Kathleen Fischer

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

Target of rapamycin inhibition by rapamycin feeding has previously been shown to extend life in genetically heterogeneous mice. To examine whether it similarly affected mouse health, we fed encapsulated rapamycin or a control diet to C57BL/6Nia mice of both sexes starting at 19 months of age. We performed a range of health assessments 6 and 12 months later. Rapamycin feeding significantly reduced mTOR activity in most but not all tissues. It also reduced total and resting metabolic rate during the light (inactive) phase of the light:dark cycle in females only but had no effect on spontaneous activity or metabolism during the dark (active) phase of either sex. Males only had less fragmented sleep when fed rapamycin, whereas stride length and rotarod performance were improved in both sexes. Survival was also improved by this late-life rapamycin feeding, and some pathological lesions were delayed. We found no adverse health consequences associated with rapamycin treatment.

Original languageEnglish (US)
Pages (from-to)119-130
Number of pages12
JournalJournals of Gerontology - Series A Biological Sciences and Medical Sciences
Volume69 A
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Sirolimus
Inbred C57BL Mouse
Health
Basal Metabolism
Photoperiod
Sleep
Diet
Light

Keywords

  • Aging
  • Health span
  • Rapamycin
  • Sex differences

ASJC Scopus subject areas

  • Aging
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Rapamycin extends life and health in C57BL/6 mice. / Zhang, Yiqiang; Bokov, Alex; Gelfond, Jonathan A; Soto, Vanessa; Ikeno, Yuji; Hubbard, Gene; Diaz, Vivian; Sloane, Lauren; Maslin, Keith; Treaster, Stephen; Réndon, Samantha; Van Remmen, Holly; Ward, Walter; Javors, Martin A; Richardson, Arlan; Austad, Steven N.; Fischer, Kathleen.

In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, Vol. 69 A, No. 2, 2014, p. 119-130.

Research output: Contribution to journalArticle

Zhang, Y, Bokov, A, Gelfond, JA, Soto, V, Ikeno, Y, Hubbard, G, Diaz, V, Sloane, L, Maslin, K, Treaster, S, Réndon, S, Van Remmen, H, Ward, W, Javors, MA, Richardson, A, Austad, SN & Fischer, K 2014, 'Rapamycin extends life and health in C57BL/6 mice', Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 69 A, no. 2, pp. 119-130. https://doi.org/10.1093/gerona/glt056
Zhang, Yiqiang ; Bokov, Alex ; Gelfond, Jonathan A ; Soto, Vanessa ; Ikeno, Yuji ; Hubbard, Gene ; Diaz, Vivian ; Sloane, Lauren ; Maslin, Keith ; Treaster, Stephen ; Réndon, Samantha ; Van Remmen, Holly ; Ward, Walter ; Javors, Martin A ; Richardson, Arlan ; Austad, Steven N. ; Fischer, Kathleen. / Rapamycin extends life and health in C57BL/6 mice. In: Journals of Gerontology - Series A Biological Sciences and Medical Sciences. 2014 ; Vol. 69 A, No. 2. pp. 119-130.
@article{be7bb8b5fab24777829287c9ba4a45f3,
title = "Rapamycin extends life and health in C57BL/6 mice",
abstract = "Target of rapamycin inhibition by rapamycin feeding has previously been shown to extend life in genetically heterogeneous mice. To examine whether it similarly affected mouse health, we fed encapsulated rapamycin or a control diet to C57BL/6Nia mice of both sexes starting at 19 months of age. We performed a range of health assessments 6 and 12 months later. Rapamycin feeding significantly reduced mTOR activity in most but not all tissues. It also reduced total and resting metabolic rate during the light (inactive) phase of the light:dark cycle in females only but had no effect on spontaneous activity or metabolism during the dark (active) phase of either sex. Males only had less fragmented sleep when fed rapamycin, whereas stride length and rotarod performance were improved in both sexes. Survival was also improved by this late-life rapamycin feeding, and some pathological lesions were delayed. We found no adverse health consequences associated with rapamycin treatment.",
keywords = "Aging, Health span, Rapamycin, Sex differences",
author = "Yiqiang Zhang and Alex Bokov and Gelfond, {Jonathan A} and Vanessa Soto and Yuji Ikeno and Gene Hubbard and Vivian Diaz and Lauren Sloane and Keith Maslin and Stephen Treaster and Samantha R{\'e}ndon and {Van Remmen}, Holly and Walter Ward and Javors, {Martin A} and Arlan Richardson and Austad, {Steven N.} and Kathleen Fischer",
year = "2014",
doi = "10.1093/gerona/glt056",
language = "English (US)",
volume = "69 A",
pages = "119--130",
journal = "Journals of Gerontology - Series A Biological Sciences and Medical Sciences",
issn = "1079-5006",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Rapamycin extends life and health in C57BL/6 mice

AU - Zhang, Yiqiang

AU - Bokov, Alex

AU - Gelfond, Jonathan A

AU - Soto, Vanessa

AU - Ikeno, Yuji

AU - Hubbard, Gene

AU - Diaz, Vivian

AU - Sloane, Lauren

AU - Maslin, Keith

AU - Treaster, Stephen

AU - Réndon, Samantha

AU - Van Remmen, Holly

AU - Ward, Walter

AU - Javors, Martin A

AU - Richardson, Arlan

AU - Austad, Steven N.

AU - Fischer, Kathleen

PY - 2014

Y1 - 2014

N2 - Target of rapamycin inhibition by rapamycin feeding has previously been shown to extend life in genetically heterogeneous mice. To examine whether it similarly affected mouse health, we fed encapsulated rapamycin or a control diet to C57BL/6Nia mice of both sexes starting at 19 months of age. We performed a range of health assessments 6 and 12 months later. Rapamycin feeding significantly reduced mTOR activity in most but not all tissues. It also reduced total and resting metabolic rate during the light (inactive) phase of the light:dark cycle in females only but had no effect on spontaneous activity or metabolism during the dark (active) phase of either sex. Males only had less fragmented sleep when fed rapamycin, whereas stride length and rotarod performance were improved in both sexes. Survival was also improved by this late-life rapamycin feeding, and some pathological lesions were delayed. We found no adverse health consequences associated with rapamycin treatment.

AB - Target of rapamycin inhibition by rapamycin feeding has previously been shown to extend life in genetically heterogeneous mice. To examine whether it similarly affected mouse health, we fed encapsulated rapamycin or a control diet to C57BL/6Nia mice of both sexes starting at 19 months of age. We performed a range of health assessments 6 and 12 months later. Rapamycin feeding significantly reduced mTOR activity in most but not all tissues. It also reduced total and resting metabolic rate during the light (inactive) phase of the light:dark cycle in females only but had no effect on spontaneous activity or metabolism during the dark (active) phase of either sex. Males only had less fragmented sleep when fed rapamycin, whereas stride length and rotarod performance were improved in both sexes. Survival was also improved by this late-life rapamycin feeding, and some pathological lesions were delayed. We found no adverse health consequences associated with rapamycin treatment.

KW - Aging

KW - Health span

KW - Rapamycin

KW - Sex differences

UR - http://www.scopus.com/inward/record.url?scp=84896800569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896800569&partnerID=8YFLogxK

U2 - 10.1093/gerona/glt056

DO - 10.1093/gerona/glt056

M3 - Article

VL - 69 A

SP - 119

EP - 130

JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences

SN - 1079-5006

IS - 2

ER -